SNCB | Synuclein, beta | | | | | | Tissue enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ZIC2 | Zic family member 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
FAM131B | Family with sequence similarity 131, member B | | | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
ANKRD34A | Ankyrin repeat domain 34A | | | | | | Tissue enriched |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
PPP4R4 | Protein phosphatase 4, regulatory subunit 4 | | | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
SOX8 | SRY (sex determining region Y)-box 8 | Transcription factors
| | | | | Tissue enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
FEZ1 | Fasciculation and elongation protein zeta 1 (zygin I) | | | | | | Tissue enriched |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | | Group enriched |
NSF | N-ethylmaleimide-sensitive factor | Enzymes Transporters
| | | | | Tissue enriched |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | | Group enriched |
SH2D5 | SH2 domain containing 5 | | | | | | Group enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins
| | | | | Group enriched |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | | | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | | | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Transporters
| | | | | Tissue enhanced |
CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | Enzymes
| | | | | Tissue enhanced |